Ticker LaunchIPO · GBS
Intelligent Bio Solutions Inc.
Formerly GBS Inc.; Glucose Biosensor Systems (Greater China) Holdings, Inc.
Intelligent Bio Solutions Inc. (GBS) priced its initial public offering on Dec 28, 2020 at $17.00 per share, within its $16.00–$18.00 range, raising $21.6M, and listed on Nasdaq. At the IPO price its market capitalization was about $192M. Dawson James was lead-left underwriter. Schiff Hardin advised the company and Ellenoff Grossman & Schole advised the underwriters.
Intelligent Bio Solutions Inc. is developing and commercializing biosensor-based point-of-care diagnostic tests in areas such as clinical chemistry, immunology, tumor markers, allergens and endocrinology. It is also collaborating with the Wyss Institute at Harvard University on a real-time SARS-CoV-2 test.
- Status
- IPO
- Ticker
- GBS
- Exchange
- Nasdaq
- Priced
- Dec 28, 2020
- IPO price
- $17.00
- Price range
- $16.00–$18.00
- Raised
- $21.6M
- Market cap at IPO price
- $192M
- First filed
- Jul 5, 2019
- Underwriters
- Dawson James
- Company counsel
- Schiff Hardin
- Underwriters' counsel
- Ellenoff Grossman & Schole
- Sector
- Healthcare
- Country / state
- NY
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jul 5, 2019
- Latest amendment Dec 21, 2020
- Final prospectus (424B4) Dec 28, 2020
- All filings on EDGAR CIK 1725430
Other Healthcare IPOs in 2020
- Vivos Therapeutics, Inc.VVOS · Dec 14, 2020 · $21M
- Sotera Health CoSHC · Nov 23, 2020 · $1.07B
- Biodesix IncBDSX · Oct 29, 2020 · $72M
- Eargo, Inc.EAR · Oct 19, 2020 · $141.3M
- Pulmonx CorpLUNG · Oct 1, 2020 · $190M
- Outset Medical, Inc.OM · Sep 16, 2020 · $241.7M